Get started
Author

Dorinja Zapf

Observed name: D Zapf
ORCID: 0000-0002-2449-0951
Observed ORCID: 0000-0002-2449-0951
OpenAlex ID: A5070406146
Long-Term Course of Humoral and Cellular Immune Responses in Outpatients After SARS-CoV-2 Infection
2021 · Julia Schiffner, Insa Backhaus, et al. · Frontiers in Public Health · 36
PDF
The temporal course of T- and B-cell responses to vaccination with BNT162b2 and mRNA-1273
2021 · Robert Markewitz, Daniela Pauli, et al. · Clinical Microbiology and Infection · 27
The HIF-1α/LC3-II Axis Impacts Fungal Immunity in Human Macrophages
2019 · Dirk Friedrich, Dorinja Zapf, et al. · Infection and Immunity · 23
Fc Receptor Inhibition Reduces Susceptibility to Oxidative Stress in Human RPE Cells Treated with Bevacizumab, but not Aflibercept
2016 · Mahdy Ranjbar, Max Philipp Brinkmann, et al. · Cellular Physiology and Biochemistry · 21
Kinetics of the Antibody Response to Boostering With Three Different Vaccines Against SARS-CoV-2
2022 · Robert Markewitz, David Juhl, et al. · Frontiers in Immunology · 14
PDF
Differences in Immunogenicity of Three Different Homo- and Heterologous Vaccination Regimens against SARS-CoV-2
2022 · Robert Daniel Heinrich Markewitz, David Juhl, et al. · Vaccines · 10
PDF
High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium
2022 · Bas Calcoen, Nico Callewaert, et al. · Viruses · 8
PDF
B-cell responses to vaccination with BNT162b2 and mRNA-1273 6 months after second dose
2022 · Robert Markewitz, Daniela Pauli, et al. · Clinical Microbiology and Infection · 8
Preliminary evaluation of a new prototype interferon-gamma release assay for the detection of Mycobacterium tuberculosis–specific T-cell responses in patients with tuberculosis
2025 · Markéta Ibrahimová, Karolína Doležalová, et al. · Folia Microbiologica · 2
Evaluation of three novel antigens and costimulatory agents for improvement of M. Tuberculosis specific interferon gamma release assays
2025 · Sandra Schwarzlose-Schwarck, Mark Reinwald, et al. · BMC Infectious Diseases · 2
PDF
Impact of Omicron Variant Infection on Assessment of Spike-Specific Immune Responses Using the EUROIMMUN Quan-T-Cell SARS-CoV-2 Assay and Roche Elecsys Anti-SARS-CoV-2-S
2023 · Mohamed I. M. Ahmed, Michael Plank, et al. · Diagnostics · 2
PDF
Pneumocystis Jirovecii Pneumonia: The Potential of KEX1, MSG1, and MSG2 as Key Antigens in Cytokine Release Assays
2025 · F. A. Ottilie Neumann, Markus Müller, et al. · Diagnostics · 1
B-108 T-cell-mediated Immunity against SARS-CoV-2 in Health Care Workers: Head-to-head Comparison of Two Interferon-Gamma Release Assays and Associations between Cellular and Humoral Immunity
2023 · M Sabalza, J Martinek, et al. · Clinical Chemistry
PDF
Fc receptor inhibition reduces susceptibility to oxidative stress in human RPE cells treated with bevacizumab, but not aflibercept.
2016 · Mahdy Ranjbar, Max Brinkmann, et al. · Investigative Ophthalmology & Visual Science
Works count: 14
Citation count: 154
H-index: 8
I10-index: 6
Year
Topic
Type